At Glaxo, a New CEO Steps In, Must Wring More From R&D

At GlaxoSmithKline, the new chief, Emma Walmsley, arrives from the company’s consumer health products operations to focus on stoking the research pipeline of new drugs.

from WSJ.com: US Business http://ift.tt/2noO7Dj
via IFTTT